Ado-trastuzumab for the treatment of metastatic HER2-positive breast cancer in patients previously treated with Pertuzumab.
Saved in:
| Title: | Ado-trastuzumab for the treatment of metastatic HER2-positive breast cancer in patients previously treated with Pertuzumab. |
|---|---|
| Authors: | Al Rabadi, Luai S.1 (AUTHOR), Cook, Madeline M.2 (AUTHOR), Kaempf, Andy J.3 (AUTHOR), Saraceni, Megan M.4 (AUTHOR), Savin, Michael A.1 (AUTHOR), Mitri, Zahi I.1 (AUTHOR) mitri@ohsu.edu |
| Source: | BMC Cancer. 10/27/2021, Vol. 21 Issue 1, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
